These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32101311)
21. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF). Fox KAA; Accetta G; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Kayani G; Kakkar AK; Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):27-35. PubMed ID: 28950344 [TBL] [Abstract][Full Text] [Related]
23. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. De Caterina R; Ammentorp B; Darius H; Le Heuzey JY; Renda G; Schilling RJ; Schliephacke T; Reimitz PE; Schmitt J; Schober C; Zamorano JL; Kirchhof P; Heart; 2014 Oct; 100(20):1625-35. PubMed ID: 25106421 [TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448 [TBL] [Abstract][Full Text] [Related]
25. Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry. Krittayaphong R; Winijkul A; Kunjara-Na-Ayudhya R; Apiyasawat S; Siriwattana K; Kanjanarutjawiwat W; Dutsadeevettakul S; Lip GYH; Stroke; 2020 Jun; 51(6):1772-1780. PubMed ID: 32390554 [TBL] [Abstract][Full Text] [Related]
26. Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF Registry. Verheugt FWA; Fox KAA; Virdone S; Ambrosio G; Gersh BJ; Haas S; Pieper KS; Kayani G; Camm AJ; Parkhomenko A; Misselwitz F; Ragy H; Ten Cate H; Keltai M; Kakkar AK; Am J Med; 2023 Dec; 136(12):1187-1195.e15. PubMed ID: 37704071 [TBL] [Abstract][Full Text] [Related]
27. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry. Fauchier L; Greenlaw N; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Steg PG; PLoS One; 2015; 10(4):e0125164. PubMed ID: 25915904 [TBL] [Abstract][Full Text] [Related]
28. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Haas S; Camm AJ; Bassand JP; Angchaisuksiri P; Cools F; Corbalan R; Gibbs H; Jacobson B; Koretsune Y; Mantovani LG; Misselwitz F; Panchenko E; Ragy HI; Stepinska J; Turpie AG; Sawhney JP; Steffel J; Lim TW; Pieper KS; Virdone S; Verheugt FW; Kakkar AK; Am Heart J; 2019 Jul; 213():35-46. PubMed ID: 31128503 [TBL] [Abstract][Full Text] [Related]
29. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry. Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937 [TBL] [Abstract][Full Text] [Related]
30. [Current use of oral anticoagulation therapy and influencing factors among coronary artery disease patients with nonvalvular atrial fibrillation in China]. Qiao Y; Wang Y; Li SN; Jiang CX; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):504-512. PubMed ID: 37198122 [No Abstract] [Full Text] [Related]
31. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention. Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357 [TBL] [Abstract][Full Text] [Related]
32. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP; JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214 [TBL] [Abstract][Full Text] [Related]
33. Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention. Khan SU; Khan MU; Ghani AR; Lone AN; Arshad A; Kaluski E Am J Cardiol; 2018 May; 121(10):1200-1206. PubMed ID: 29548674 [TBL] [Abstract][Full Text] [Related]
34. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
35. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Inohara T; Shrader P; Pieper K; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Go AS; Ezekowitz MD; Kowey PR; Reiffel JA; Naccarelli GV; Chan PS; Mahaffey KW; Singer DE; Freeman JV; Steinberg BA; Peterson ED; Piccini JP; Am Heart J; 2019 Jul; 213():81-90. PubMed ID: 31129441 [TBL] [Abstract][Full Text] [Related]
36. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF. Koretsune Y; Etoh T; Katsuda Y; Suetsugu T; Kumeda K; Sakuma I; Eshima K; Shibuya M; Ando SI; Yokota N; Goto S; Pieper KS; Allu J; Kakkar AK; Circ J; 2018 Dec; 83(1):67-74. PubMed ID: 30518731 [TBL] [Abstract][Full Text] [Related]
37. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study. Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342 [TBL] [Abstract][Full Text] [Related]
38. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study. Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435 [TBL] [Abstract][Full Text] [Related]
39. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry. Cools F; Johnson D; Camm AJ; Bassand JP; Verheugt FWA; Yang S; Tsiatis A; Fitzmaurice DA; Goldhaber SZ; Kayani G; Goto S; Haas S; Misselwitz F; Turpie AGG; Fox KAA; Pieper KS; Kakkar AK; J Thromb Haemost; 2021 Sep; 19(9):2322-2334. PubMed ID: 34060704 [TBL] [Abstract][Full Text] [Related]
40. Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry. Hsu JC; Maddox TM; Kennedy KF; Katz DF; Marzec LN; Lubitz SA; Gehi AK; Turakhia MP; Marcus GM JAMA Cardiol; 2016 Apr; 1(1):55-62. PubMed ID: 27437655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]